Bio-Rad Laboratories (BIO.B) Competitors $225.29 0.00 (0.00%) As of 04/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock BIO.B vs. KEYS, VLTO, FTV, TER, RVTY, AVTR, NVMI, VNT, MIR, and STShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Nova (NVMI), Vontier (VNT), Mirion Technologies (MIR), and Sensata Technologies (ST). These companies are all part of the "measuring and control equipment" industry. Bio-Rad Laboratories vs. Keysight Technologies Veralto Fortive Teradyne Revvity Avantor Nova Vontier Mirion Technologies Sensata Technologies Bio-Rad Laboratories (NYSE:BIO.B) and Keysight Technologies (NYSE:KEYS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation, community ranking and profitability. Does the MarketBeat Community favor BIO.B or KEYS? Keysight Technologies received 356 more outperform votes than Bio-Rad Laboratories when rated by MarketBeat users. Likewise, 66.25% of users gave Keysight Technologies an outperform vote while only 57.60% of users gave Bio-Rad Laboratories an outperform vote. CompanyUnderperformOutperformBio-Rad LaboratoriesOutperform Votes12557.60% Underperform Votes9242.40% Keysight TechnologiesOutperform Votes48166.25% Underperform Votes24533.75% Is BIO.B or KEYS more profitable? Keysight Technologies has a net margin of 12.32% compared to Bio-Rad Laboratories' net margin of -71.86%. Keysight Technologies' return on equity of 19.22% beat Bio-Rad Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-71.86% 3.90% 2.76% Keysight Technologies 12.32%19.22%10.52% Does the media favor BIO.B or KEYS? In the previous week, Keysight Technologies had 22 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 23 mentions for Keysight Technologies and 1 mentions for Bio-Rad Laboratories. Keysight Technologies' average media sentiment score of 1.14 beat Bio-Rad Laboratories' score of -0.62 indicating that Keysight Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Keysight Technologies 18 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Which has more volatility & risk, BIO.B or KEYS? Bio-Rad Laboratories has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Keysight Technologies has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Do insiders & institutionals believe in BIO.B or KEYS? 0.0% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 84.6% of Keysight Technologies shares are held by institutional investors. 28.4% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 0.6% of Keysight Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings and valuation, BIO.B or KEYS? Keysight Technologies has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Keysight Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.57B2.46-$1.84B-$65.04-3.46Keysight Technologies$5.02B4.72$614M$3.4939.24 Do analysts prefer BIO.B or KEYS? Keysight Technologies has a consensus price target of $184.44, suggesting a potential upside of 34.69%. Given Keysight Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Keysight Technologies is more favorable than Bio-Rad Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Keysight Technologies 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.78 SummaryKeysight Technologies beats Bio-Rad Laboratories on 17 of the 18 factors compared between the two stocks. Remove Ads Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO.B vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$6.31B$4.13B$5.33B$18.53BDividend YieldN/A0.59%5.11%4.23%P/E Ratio-3.4626.9021.7031.15Price / Sales2.464.17377.7225.69Price / Cash30.0336.1138.1517.53Price / Book0.961.696.464.29Net Income-$1.84B-$83.57M$3.20B$1.02B7 Day PerformanceN/A4.35%2.77%-0.79%1 Month Performance-15.25%-6.67%-8.60%-6.88%1 Year Performance-33.45%-32.35%10.40%1.74% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIO.BBio-Rad LaboratoriesN/A$225.29flatN/A-33.5%$6.31B$2.57B-3.468,200KEYSKeysight Technologies4.6915 of 5 stars$136.23+2.0%$184.44+35.4%-10.7%$23.54B$5.02B38.9215,000Positive NewsGap UpVLTOVeralto3.4478 of 5 stars$90.64+1.1%$111.90+23.5%+0.2%$22.48B$5.19B27.1416,000Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsFTVFortive4.5104 of 5 stars$66.07+1.7%$81.92+24.0%-19.4%$22.48B$6.23B28.0018,000Upcoming EarningsAnalyst ForecastTERTeradyne4.9601 of 5 stars$73.86+0.3%$121.44+64.4%-29.1%$11.85B$2.82B22.186,500Short Interest ↓Positive NewsRVTYRevvity3.8775 of 5 stars$97.51+2.8%$133.75+37.2%-6.6%$11.72B$2.76B44.1211,500Positive NewsAVTRAvantor4.7344 of 5 stars$15.56+2.2%$25.08+61.2%-37.6%$10.60B$6.78B14.9614,500Positive NewsGap UpNVMINova2.9361 of 5 stars$184.16+2.4%$250.83+36.2%+9.6%$5.39B$672.40M32.081,180Analyst ForecastPositive NewsGap UpVNTVontier3.8612 of 5 stars$30.27+1.1%$43.17+42.6%-26.4%$4.50B$2.98B11.018,100Analyst ForecastPositive NewsGap DownMIRMirion Technologies2.3378 of 5 stars$13.73+0.1%$18.00+31.1%+33.0%$3.19B$860.80M-72.262,870Analyst ForecastGap DownSTSensata Technologies4.8283 of 5 stars$20.00+2.2%$36.73+83.6%-41.9%$2.99B$3.93B23.8120,800Analyst ForecastGap Down Remove Ads Related Companies and Tools Related Companies KEYS Competitors VLTO Competitors FTV Competitors TER Competitors RVTY Competitors AVTR Competitors NVMI Competitors VNT Competitors MIR Competitors ST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO.B) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIO.B Stock Free BIO.B Stock Alerts